drugset / Trial / NCT00535691

Tacrolimus Ointment Pharmacokinetics in Infants With Atopic Dermatitis

NCT00535691 ↗

Phase 2 Completed 53 enrolled Astellas Pharma Inc
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to estimate the systemic exposure to tacrolimus in infants with atopic dermatitis after repeated application of tacrolimus ointment. Efficacy of tacrolimus ointment, evaluated by examination of treated areas, will also be measured.

Timeline

Start
2003-04
Primary completion
—
Completion
2004-12

Drugs

EvaluationDrugModalityDoseRoute
Comparator Tacrolimus Small molecule 0.03 % Topical

Indications